(GLSI) - Greenwich LifeSciences Surges 2000%, Halted Multiple ... - dofaq.co
(GLSI) - Greenwich LifeSciences Surges 2000%, Halted Multiple ...
Benzinga - 10 Dec 2020
Greenwich LifeSciences (NASDAQ: GLSI) shares spiked 1900% higher Wednesday after the company shared the poster for the GP2 Phase 2b clinical ...
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
GlobeNewswire - 17 Mar 2025
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01 ...
Recent 15% decline may not have gone down well with Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who've been purchasing recently
simplywall.st - 01 Apr 2025
Recent 15% decline may not have gone down well with Greenwich LifeSciences, Inc. (NASDAQ:GLSI) insiders who've been purchasing recently ...
(GLSI) Trading Signals
news.stocktradersdaily.com - 25 Jun 2025
(GLSI) Trading Signals ...
Greenwich LifeSciences: Long Time To Results, Little Cash, Hard To Recommend (GLSI)
Seeking Alpha - 06 Feb 2025
Greenwich LifeSciences: Long Time To Results, Little Cash, Hard To Recommend (GLSI) ...
Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Livingston Daily - 28 Jun 2025
Greenwich LifeSciences Interview to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV ...
Greenwich's Breast Cancer Drug Proves Safe in Phase III Trial, Building on 80% Recurrence Reduction
Stock Titan - 17 Mar 2025
Greenwich's Breast Cancer Drug Proves Safe in Phase III Trial, Building on 80% Recurrence Reduction ...
InvestingPro’s bearish call on GLSI captures 42% downside movement By Investing.com
Investing.com - 07 Jun 2025
InvestingPro’s bearish call on GLSI captures 42% downside movement By Investing.com ...
Greenwich LifeSciences: What The Recent Data Do For The Investment Thesis (GLSI)
Seeking Alpha - 09 May 2025
Greenwich LifeSciences: What The Recent Data Do For The Investment Thesis (GLSI) ...
Clinical Trial Success: GLSI's Breast Cancer Therapy Shows Promising Results in Expanded Patient Group
Stock Titan - 02 Apr 2025
Clinical Trial Success: GLSI's Breast Cancer Therapy Shows Promising Results in Expanded Patient Group ...
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
GlobeNewswire - 27 Mar 2025
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026 ...
Major Insider Confidence Signal: Greenwich LifeSciences Leadership Locks Shares Until 2026
Stock Titan - 27 Mar 2025
Major Insider Confidence Signal: Greenwich LifeSciences Leadership Locks Shares Until 2026 ...
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
GlobeNewswire - 10 Feb 2025
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01 ...
Greenwich LifeSciences Provides Update on Commercial Manufacturing
GlobeNewswire - 22 Jan 2025
Greenwich LifeSciences Provides Update on Commercial Manufacturing ...
55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently
Yahoo Finance - 05 Mar 2025
55% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) is owned by insiders, and they've been buying recently ...
Greenwich LifeSciences Provides Global Update on FLAMINGO-01
GlobeNewswire - 03 Apr 2025
Greenwich LifeSciences Provides Global Update on FLAMINGO-01 ...
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
GlobeNewswire - 23 Jan 2025
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01 ...
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
GlobeNewswire - 02 Apr 2025
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial ...
Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial
Curetoday - 03 Apr 2025
Investigative Agent Elicits Responses in Phase 3 Breast Cancer Trial ...
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
GlobeNewswire - 13 Jan 2025
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France ...